{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T04:23:55Z","timestamp":1778559835039,"version":"3.51.4"},"publisher-location":"Cham","reference-count":90,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783319442501","type":"print"},{"value":"9783319442518","type":"electronic"}],"license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016]]},"DOI":"10.1007\/5584_2016_79","type":"book-chapter","created":{"date-parts":[[2016,10,8]],"date-time":"2016-10-08T08:55:04Z","timestamp":1475916904000},"page":"599-613","source":"Crossref","is-referenced-by-count":26,"title":["Metabolomics, Lipidomics and Pharmacometabolomics of Human Hypertension"],"prefix":"10.1007","author":[{"given":"Anthony","family":"Au","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kian-Kai","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loo Keat","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"79_CR1","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3389\/fbioe.2015.00023","volume":"3","author":"A Alonso","year":"2015","unstructured":"Alonso A, Marsal S, Juli\u00e0 A (2015) Analytical methods in untargeted metabolomics: state of the art in 2015. Front Bioeng Biotechnol 3:23","journal-title":"Front Bioeng Biotechnol"},{"issue":"5","key":"79_CR2","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s10654-014-9910-7","volume":"29","author":"E Altmaier","year":"2014","unstructured":"Altmaier E, Fobo G, Heier M, Thorand B, Meisinger C, Romisch-Margl W et al (2014) Metabolomics approach reveals effects of antihypertensives and lipid-lowering drugs on the human metabolism. Eur J Epidemiol 29(5):325\u2013336","journal-title":"Eur J Epidemiol"},{"issue":"1","key":"79_CR3","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1743-7075-8-45","volume":"8","author":"SH Ardiansyah","year":"2011","unstructured":"Ardiansyah SH, Inagawa Y, Koseki T, Komai M (2011) Regulation of blood pressure and glucose metabolism induced by L-tryptophan in stroke-prone spontaneously hypertensive rats. Nutr Metabol 8(1):45\u201352","journal-title":"Nutr Metabol"},{"issue":"5","key":"79_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5936\/csbj.201301009","volume":"4","author":"J Bartel","year":"2013","unstructured":"Bartel J, Krumsiek J, Theis FJ (2013) Statistical methods for the analysis of high-throughput metabolomics data. Comput Struct Biotechnol J 4(5):1\u20139","journal-title":"Comput Struct Biotechnol J"},{"issue":"6","key":"79_CR5","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1038\/nprot.2010.45","volume":"5","author":"O Beckonert","year":"2010","unstructured":"Beckonert O, Coen M, Keun HC, Wang Y, Ebbels TMD, Holmes E et al (2010) High-resolution magic-angle-spinning NMR spectroscopy for metabolic profiling of intact tissues. Nat Protoc 5(6):1019\u20131032","journal-title":"Nat Protoc"},{"issue":"2","key":"79_CR6","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1111\/j.1469-185X.2010.00157.x","volume":"86","author":"JH Bothwell","year":"2011","unstructured":"Bothwell JH, Griffin JL (2011) An introduction to biological nuclear magnetic resonance spectroscopy. Biol Rev Camb Philos Soc 86(2):493\u2013510","journal-title":"Biol Rev Camb Philos Soc"},{"issue":"2","key":"79_CR7","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.ab.2007.09.037","volume":"372","author":"SJ Bruce","year":"2008","unstructured":"Bruce SJ, Jonsson P, Antti H, Cloarec O, Trygg J, Marklund SL et al (2008) Evaluation of a protocol for metabolic profiling studies on human blood plasma by combined ultra-performance liquid chromatography\/mass spectrometry: From extraction to data analysis. Anal Biochem 372(2):237\u2013249","journal-title":"Anal Biochem"},{"issue":"1","key":"79_CR8","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1021\/pr500756u","volume":"14","author":"K-K Cheng","year":"2014","unstructured":"Cheng K-K, Akasaki Y, Lecommandeur E, Lindsay RT, Murfitt S, Walsh K et al (2014) Metabolomic analysis of akt1-mediated muscle hypertrophy in models of diet-induced obesity and age-related fat accumulation. J Proteome Res 14(1):342\u2013352","journal-title":"J Proteome Res"},{"issue":"6","key":"79_CR9","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1161\/01.HYP.0000107251.49515.c2","volume":"42","author":"AV Chobanian","year":"2003","unstructured":"Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL et al (2003) Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 42(6):1206\u20131252","journal-title":"Hypertension"},{"issue":"3","key":"79_CR10","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/sj.jhh.1001323","volume":"16","author":"M Cirillo","year":"2002","unstructured":"Cirillo M, Lombardi C, Laurenzi M, De Santo NG (2002) Relation of urinary urea to blood pressure: interaction with urinary sodium. J Hum Hypertens 16(3):205\u2013212","journal-title":"J Hum Hypertens"},{"issue":"1","key":"79_CR11","doi-asserted-by":"crossref","first-page":"H275","DOI":"10.1152\/ajpheart.2001.281.1.H275","volume":"281","author":"M Cyr","year":"2001","unstructured":"Cyr M, Lepage Y, Blais C, Gervais N, Cugno M, Rouleau JL et al (2001) Bradykinin and des-Arg9-bradykinin metabolic pathways and kinetics of activation of human plasma. Am J Physiol Heart Circ Physiol 281(1):H275\u2013H283","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"11","key":"79_CR12","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.2337\/diabetes.53.11.2873","volume":"53","author":"RT Jongh de","year":"2004","unstructured":"de Jongh RT, Sern\u00e9 EH, Ijzerman RG, de Vries G, Stehouwer CDA (2004) Free fatty acid levels modulate microvascular function relevance for obesity-associated insulin resistance, hypertension, and microangiopathy. Diabetes 53(11):2873\u20132882","journal-title":"Diabetes"},{"issue":"10","key":"79_CR13","doi-asserted-by":"publisher","first-page":"3783","DOI":"10.1021\/ac7025964","volume":"80","author":"T Meyer De","year":"2008","unstructured":"De Meyer T, Sinnaeve D, Van Gasse B, Tsiporkova E, Rietzschel ER, De Buyzere ML et al (2008) NMR-based characterization of metabolic alterations in hypertension using an adaptive, intelligent binning algorithm. Anal Chem 80(10):3783\u20133790","journal-title":"Anal Chem"},{"issue":"2","key":"79_CR14","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/j.1365-2125.1978.tb01611.x","volume":"5","author":"SP Deacon","year":"1978","unstructured":"Deacon SP (1978) The effects of atenolol and propranolol upon lipolysis. Br J Clin Pharmacol 5(2):123\u2013125","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"79_CR15","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1586\/erc.10.27","volume":"8","author":"JD Duarte","year":"2010","unstructured":"Duarte JD, Cooper-DeHoff RM (2010) Mechanisms for blood pressure lowering and metabolic effects of thiazide and thiazide-like diuretics. Expert Rev Cardiovasc 8(6):793\u2013802","journal-title":"Expert Rev Cardiovasc"},{"key":"79_CR16","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/B978-0-12-381264-3.00002-3","volume":"80","author":"E Dudley","year":"2010","unstructured":"Dudley E, Yousef M, Wang Y, Griffiths WJ (2010) Targeted metabolomics and mass spectrometry. Adv Protein Chem Struct Biol 80:45\u201383","journal-title":"Adv Protein Chem Struct Biol"},{"issue":"1","key":"79_CR17","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1039\/B906712B","volume":"40","author":"WB Dunn","year":"2011","unstructured":"Dunn WB, Broadhurst DI, Atherton HJ, Goodacre R, Griffin JL (2011) Systems level studies of mammalian metabolomes: the roles of mass spectrometry and nuclear magnetic resonance spectroscopy. Chem Soc Rev 40(1):387\u2013426","journal-title":"Chem Soc Rev"},{"issue":"2","key":"79_CR18","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1161\/HYPERTENSIONAHA.109.129171","volume":"54","author":"DH Ellison","year":"2009","unstructured":"Ellison DH, Loffing J (2009) Thiazide effects and adverse effects: insights from molecular genetics. Hypertension 54(2):196\u2013202","journal-title":"Hypertension"},{"issue":"5","key":"79_CR19","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1093\/ije\/27.5.808","volume":"27","author":"A Fagot-Campagna","year":"1998","unstructured":"Fagot-Campagna A, Balkau B, Simon D, Warnet J-M, Claude J-R, Ducimetl\u00e8red P et al (1998) High free fatty acid concentration: an independent risk factor for hypertension in the Paris Prospective Study. Int J Epidemiol 27(5):808\u2013813","journal-title":"Int J Epidemiol"},{"issue":"23","key":"79_CR20","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1007\/BF01782468","volume":"62","author":"H Feltkamp","year":"1984","unstructured":"Feltkamp H, Meurer KA, Godehardt E (1984) Tryptophan-induced lowering of blood pressure and changes of serotonin uptake by platelets in patients with essential hypertension. Klin Wochenschr 62(23):1115\u20131119","journal-title":"Klin Wochenschr"},{"issue":"6","key":"79_CR21","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1139\/y89-105","volume":"67","author":"MJ Fregly","year":"1989","unstructured":"Fregly MJ, Sumners C, Cade JR (1989) Effect of chronic dietary treatment with L-tryptophan on the maintenance of hypertension in spontaneously hypertensive rats. Can J Physiol Pharmacol 67(6):656\u2013662","journal-title":"Can J Physiol Pharmacol"},{"issue":"1","key":"79_CR22","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0025-7125(16)30786-6","volume":"72","author":"WH Frishman","year":"1988","unstructured":"Frishman WH (1988) Beta-adrenergic blockers. Medic Clin North Am 72(1):37\u201381","journal-title":"Medic Clin North Am"},{"key":"79_CR23","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.copbio.2014.08.006","volume":"31","author":"T Fuhrer","year":"2015","unstructured":"Fuhrer T, Zamboni N (2015) High-throughput discovery metabolomics. Curr Opin Biotechnol 31:73\u201378","journal-title":"Curr Opin Biotechnol"},{"key":"79_CR24","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1097\/00005344-199306226-00015","volume":"22","author":"S Gambardella","year":"1993","unstructured":"Gambardella S, Frontoni S, Pellegrinotti M, Testa G, Spallone V, Menzinger G (1993) Carbohydrate metabolism in hypertension: influence of treatment. J Cardiovasc Pharmacol 22:87\u201397","journal-title":"J Cardiovasc Pharmacol"},{"issue":"4","key":"79_CR25","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.amjmed.2005.09.010","volume":"119","author":"J Garc\u00eda-Puig","year":"2006","unstructured":"Garc\u00eda-Puig J, Ruilope LM, Luque M, Fern\u00e1ndez J, Ortega R, Dal-R\u00e9 R et al (2006) Glucose metabolism in patients with essential hypertension. Am J Medic 119(4):318\u2013326","journal-title":"Am J Medic"},{"issue":"7","key":"79_CR26","doi-asserted-by":"publisher","first-page":"e6261","DOI":"10.1371\/journal.pone.0006261","volume":"4","author":"J Graessler","year":"2009","unstructured":"Graessler J, Schwudke D, Schwarz PEH, Herzog R, Shevchenko A, Bornstein SR (2009) Top-down lipidomics reveals ether lipid deficiency in blood plasma of hypertensive patients. PLoS ONE 4(7):e6261","journal-title":"PLoS ONE"},{"issue":"32","key":"79_CR27","doi-asserted-by":"publisher","first-page":"5426","DOI":"10.1002\/anie.200905579","volume":"49","author":"WJ Griffiths","year":"2010","unstructured":"Griffiths WJ, Koal T, Wang Y, Kohl M, Enot DP, Deigner HP (2010) Targeted metabolomics for biomarker discovery. Angew Chem Int Ed Engl 49(32):5426\u20135445","journal-title":"Angew Chem Int Ed Engl"},{"issue":"2","key":"79_CR28","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/0006-291X(85)90140-8","volume":"128","author":"D Grobelny","year":"1985","unstructured":"Grobelny D, Galardy RE (1985) A metabolite of aspartame inhibits angiotensin converting enzyme. Biochem Biophys Res Commun 128(2):960\u2013964","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"79_CR29","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/nrm2329","volume":"9","author":"YA Hannun","year":"2008","unstructured":"Hannun YA, Obeid LM (2008) Principles of bioactive lipid signalling: lessons from sphingolipids. Nat Rev Mol Cell Biol 9(2):139\u2013150","journal-title":"Nat Rev Mol Cell Biol"},{"key":"79_CR30","doi-asserted-by":"publisher","unstructured":"Hao Y, Wang Y, Xi L, Li G, Zhao F, Qi Y, et al (2016) A nested case-control study of association between metabolome and hypertension risk. BioMed Res Int 2016:7646979","DOI":"10.1155\/2016\/7646979"},{"issue":"7193","key":"79_CR31","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/nature06882","volume":"453","author":"E Holmes","year":"2008","unstructured":"Holmes E, Loo RL, Stamler J, Bictash M, Yap IKS, Chan Q et al (2008) Human metabolic phenotype diversity and its association with diet and blood pressure. Nature 453(7193):396\u2013400","journal-title":"Nature"},{"issue":"10","key":"79_CR32","doi-asserted-by":"publisher","first-page":"e13318","DOI":"10.1371\/journal.pone.0013318","volume":"5","author":"C Hu","year":"2010","unstructured":"Hu C, Hoene M, Zhao X, Haring HU, Schleicher E, Lehmann R et al (2010) Lipidomics analysis reveals efficient storage of hepatic triacylglycerides enriched in unsaturated fatty acids after one bout of exercise in mice. PLoS ONE 5(10):e13318","journal-title":"PLoS ONE"},{"issue":"12","key":"79_CR33","doi-asserted-by":"publisher","first-page":"3271","DOI":"10.1039\/c1mb05342f","volume":"7","author":"C Hu","year":"2011","unstructured":"Hu C, Kong H, Qu F, Li Y, Yu Z, Gao P et al (2011) Application of plasma lipidomics in studying the response of patients with essential hypertension to antihypertensive drug therapy. Mol Biosyst 7(12):3271\u20133279","journal-title":"Mol Biosyst"},{"issue":"1","key":"79_CR34","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/j.1524-6175.2005.05278.x","volume":"8","author":"TA Jacobson","year":"2006","unstructured":"Jacobson TA, Zimmerman FH (2006) Fibrates in combination with statins in the management of dyslipidemia. J Clin Hypertens 8(1):35\u201341","journal-title":"J Clin Hypertens"},{"issue":"1","key":"79_CR35","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1021\/ac5040693","volume":"87","author":"CH Johnson","year":"2014","unstructured":"Johnson CH, Ivanisevic J, Benton HP, Siuzdak G (2014) Bioinformatics: the next frontier of metabolomics. Anal Chem 87(1):147\u2013156","journal-title":"Anal Chem"},{"issue":"11","key":"79_CR36","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.bbalip.2011.06.025","volume":"1811","author":"HR Jung","year":"2011","unstructured":"Jung HR, Sylv\u00e4nne T, Koistinen KM, Tarasov K, Kauhanen D, Ekroos K (2011) High throughput quantitative molecular lipidomics. Biochim Biophys Acta 1811(11):925\u2013934","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"79_CR37","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/clpt.2013.217","volume":"95","author":"R Kaddurah-Daouk","year":"2014","unstructured":"Kaddurah-Daouk R, Weinshilboum RM, Network PR (2014) Pharmacometabolomics: implications for clinical pharmacology and systems pharmacology. Clin Pharmacol Ther 95(2):154\u2013167","journal-title":"Clin Pharmacol Ther"},{"key":"79_CR38","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/978-1-61737-985-7_19","volume":"708","author":"HC Keun","year":"2011","unstructured":"Keun HC, Athersuch TJ (2011) Nuclear magnetic resonance (NMR)-based metabolomics. Methods Mol Biol 708:321\u2013334","journal-title":"Methods Mol Biol"},{"issue":"1\u20134","key":"79_CR39","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s12566-010-0015-9","volume":"2","author":"T Kind","year":"2010","unstructured":"Kind T, Fiehn O (2010) Advances in structure elucidation of small molecules using mass spectrometry. Bioanal Rev 2(1\u20134):23\u201360","journal-title":"Bioanal Rev"},{"issue":"3","key":"79_CR40","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1161\/HYPERTENSIONAHA.113.01396","volume":"62","author":"H Kulkarni","year":"2013","unstructured":"Kulkarni H, Meikle PJ, Mamtani M, Weir JM, Barlow CK, Jowett JB et al (2013) Plasma lipidomic profile signature of hypertension in Mexican American families: specific role of diacylglycerols. Hypertension 62(3):621\u2013626","journal-title":"Hypertension"},{"key":"79_CR41","doi-asserted-by":"publisher","unstructured":"Lane AN (2012) Principles of NMR for Applications in Metabolomics. Handbook Metabol 127\u2013197","DOI":"10.1007\/978-1-61779-618-0_6"},{"issue":"1","key":"79_CR42","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1021\/ac504075g","volume":"87","author":"CK Larive","year":"2014","unstructured":"Larive CK, Barding GA Jr, Dinges MM (2014) NMR spectroscopy for metabolomics and metabolic profiling. Anal Chem 87(1):133\u2013146","journal-title":"Anal Chem"},{"issue":"2","key":"79_CR43","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1021\/pr0605217","volume":"6","author":"EM Lenz","year":"2007","unstructured":"Lenz EM, Wilson ID (2007) Analytical strategies in metabonomics. J Proteome Res 6(2):443\u2013458","journal-title":"J Proteome Res"},{"issue":"5","key":"79_CR44","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1007\/s00216-011-4880-z","volume":"400","author":"Y Liu","year":"2011","unstructured":"Liu Y, Chen T, Qiu Y, Cheng Y, Cao Y, Zhao A et al (2011) An ultrasonication-assisted extraction and derivatization protocol for GC\/TOFMS-based metabolite profiling. Anal Bioanal Chem 400(5):1405\u20131417","journal-title":"Anal Bioanal Chem"},{"issue":"1","key":"79_CR45","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/pca.1186","volume":"21","author":"C Ludwig","year":"2010","unstructured":"Ludwig C, Viant MR (2010) Two\u2010dimensional J\u2010resolved NMR spectroscopy: review of a key methodology in the metabolomics toolbox. Phytochem Anal 21(1):22\u201332","journal-title":"Phytochem Anal"},{"issue":"1","key":"79_CR46","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.aca.2009.11.042","volume":"659","author":"R Madsen","year":"2010","unstructured":"Madsen R, Lundstedt T, Trygg J (2010) Chemometrics in metabolomics\u2014a review in human disease diagnosis. Anal Chim Acta 659(1):23\u201333","journal-title":"Anal Chim Acta"},{"key":"79_CR47","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1743-7075-2-25","volume":"2","author":"WF Martin","year":"2005","unstructured":"Martin WF, Armstrong LE, Rodriguez NR (2005) Dietary protein intake and renal function. Nutr Metabol 2:25","journal-title":"Nutr Metabol"},{"issue":"1","key":"79_CR48","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/art.33315","volume":"64","author":"MA McAdams DeMarco","year":"2012","unstructured":"McAdams DeMarco MA, Maynard JW, Baer AN, Gelber AC, Young JH, Alonso A et al (2012) Diuretic use, increased serum urate levels, and risk of incident gout in a population\u2010based study of adults with hypertension: The Atherosclerosis Risk in Communities cohort study. Arthritis Rheum 64(1):121\u2013129","journal-title":"Arthritis Rheum"},{"issue":"9587","key":"79_CR49","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/S0140-6736(07)61299-9","volume":"370","author":"FH Messerli","year":"2007","unstructured":"Messerli FH, Williams B, Ritz E (2007) Essential hypertension. Lancet 370(9587):591\u2013603","journal-title":"Lancet"},{"issue":"1","key":"79_CR50","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1152\/jappl.1998.85.1.181","volume":"85","author":"L Millet","year":"1998","unstructured":"Millet L, Barbe P, Lafontan M, Berlan M, Galitzky J (1998) Catecholamine effects on lipolysis and blood flow in human abdominal and femoral adipose tissue. J Appl Physiol 85(1):181\u2013188","journal-title":"J Appl Physiol"},{"issue":"5","key":"79_CR51","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1038\/ki.2013.497","volume":"85","author":"MA Niewczas","year":"2014","unstructured":"Niewczas MA, Sirich TL, Mathew AV, Skupien J, Mohney RP, Warram JH et al (2014) Uremic solutes and risk of end-stage renal disease in type 2 diabetes: metabolomic study. Kidney Int 85(5):1214\u20131224","journal-title":"Kidney Int"},{"key":"79_CR89","doi-asserted-by":"publisher","unstructured":"Nikolic SB, Sharman JE, Adams MJ, Edwards LM (2014) Metabolomics in hypertension. J Hypertens 32(6):1159\u20131169","DOI":"10.1097\/HJH.0000000000000168"},{"issue":"24","key":"79_CR52","doi-asserted-by":"publisher","first-page":"3460","DOI":"10.1002\/jssc.201100532","volume":"34","author":"GJ Patti","year":"2011","unstructured":"Patti GJ (2011) Separation strategies for untargeted metabolomics. J Sep Sci 34(24):3460\u20133469","journal-title":"J Sep Sci"},{"issue":"4","key":"79_CR53","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/nrm3314","volume":"13","author":"GJ Patti","year":"2012","unstructured":"Patti GJ, Yanes O, Siuzdak G (2012) Innovation: Metabolomics: the apogee of the omics trilogy. Nat Rev Mol Cell Biol 13(4):263\u2013269","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"79_CR54","first-page":"19","volume":"30","author":"JJ Pitt","year":"2009","unstructured":"Pitt JJ (2009) Principles and applications of liquid chromatography-mass spectrometry in clinical biochemistry. Clin Biochem Rev 30(1):19\u201334","journal-title":"Clin Biochem Rev"},{"issue":"9995","key":"79_CR55","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/S0140-6736(14)61468-9","volume":"386","author":"NR Poulter","year":"2015","unstructured":"Poulter NR, Prabhakaran D, Caulfield M (2015) Hypertension. Lancet 386(9995):801\u2013812","journal-title":"Lancet"},{"issue":"2","key":"79_CR56","doi-asserted-by":"publisher","first-page":"e16957","DOI":"10.1371\/journal.pone.0016957","volume":"6","author":"N Psychogios","year":"2011","unstructured":"Psychogios N, Hau DD, Peng J, Guo AC, Mandal R, Bouatra S et al (2011) The human serum metabolome. PLoS ONE 6(2):e16957","journal-title":"PLoS ONE"},{"key":"79_CR57","doi-asserted-by":"publisher","unstructured":"Roberts LD, Souza AL, Gerszten RE, Clish CB (2012) Targeted metabolomics. Curr Protoc Mol Biol Chapter 30:Unit 30.2.1\u201324","DOI":"10.1002\/0471142727.mb3002s98"},{"issue":"11","key":"79_CR58","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1002\/psp4.12017","volume":"4","author":"DM Rotroff","year":"2015","unstructured":"Rotroff DM, Shahin MH, Gurley SB, Zhu H, Motsinger-Reif A, Meisner M et al (2015) Pharmacometabolomic Assessments of Atenolol and Hydrochlorothiazide Treatment Reveal Novel Drug Response Phenotypes. CPT Pharm Syst Pharmacol 4(11):669\u2013679","journal-title":"CPT Pharm Syst Pharmacol"},{"key":"79_CR59","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/B978-0-12-385118-5.00017-7","volume":"500","author":"R Salek","year":"2011","unstructured":"Salek R, Cheng K-K, Griffin J (2011) The study of mammalian metabolism through NMR-based metabolomics. Methods Enzymol 500:337\u2013351","journal-title":"Methods Enzymol"},{"key":"79_CR60","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.mex.2014.07.002","volume":"1","author":"SC Sapcariu","year":"2014","unstructured":"Sapcariu SC, Kanashova T, Weindl D, Ghelfi J, Dittmar G, Hiller K (2014) Simultaneous extraction of proteins and metabolites from cells in culture. MethodsX 1:74\u201380","journal-title":"MethodsX"},{"issue":"3","key":"79_CR61","doi-asserted-by":"publisher","first-page":"718","DOI":"10.2337\/db14-0509","volume":"64","author":"KM Sas","year":"2015","unstructured":"Sas KM, Karnovsky A, Michailidis G, Pennathur S (2015) Metabolomics and diabetes: analytical and computational approaches. Diabetes 64(3):718\u2013732","journal-title":"Diabetes"},{"key":"79_CR62","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1146\/annurev-nutr-010510-103954","volume":"30","author":"V Savica","year":"2010","unstructured":"Savica V, Bellinghieri G, Kopple JD (2010) The effect of nutrition on blood pressure. Annu Rev Nutr 30:365\u2013401","journal-title":"Annu Rev Nutr"},{"issue":"6","key":"79_CR63","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/S0895-7061(97)00062-9","volume":"10","author":"LA Sechi","year":"1997","unstructured":"Sechi LA, Catena C, Zingaro L, De Carli S, Bartoli E (1997) Hypertension and abnormalities of carbohydrate metabolism possible role of the sympathetic nervous system. Am J Hypertens 10(6):678\u2013682","journal-title":"Am J Hypertens"},{"issue":"8","key":"79_CR64","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1038\/nprot.2011.366","volume":"6","author":"CA Sellick","year":"2011","unstructured":"Sellick CA, Hansen R, Stephens GM, Goodacre R, Dickson AJ (2011) Metabolite extraction from suspension-cultured mammalian cells for global metabolite profiling. Nat Protoc 6(8):1241\u20131249","journal-title":"Nat Protoc"},{"issue":"3","key":"79_CR65","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1007\/s11906-009-0032-7","volume":"11","author":"JN Sharma","year":"2009","unstructured":"Sharma JN (2009) Hypertension and the bradykinin system. Curr Hypertens Rep 11(3):178\u2013181","journal-title":"Curr Hypertens Rep"},{"issue":"2","key":"79_CR66","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1093\/bib\/bbl012","volume":"7","author":"V Shulaev","year":"2006","unstructured":"Shulaev V (2006) Metabolomics technology and bioinformatics. Brief Bioinform 7(2):128\u2013139","journal-title":"Brief Bioinform"},{"issue":"2\u20133","key":"79_CR67","first-page":"243","volume":"9","author":"RA Skidgel","year":"1987","unstructured":"Skidgel RA, Erd\u00f6s EG (1987) The broad substrate specificity of human angiotensin I converting enzyme. Clin Exp Hypertens A 9(2\u20133):243\u2013259","journal-title":"Clin Exp Hypertens A"},{"issue":"7","key":"79_CR68","doi-asserted-by":"publisher","first-page":"e21817","DOI":"10.1371\/journal.pone.0021817","volume":"6","author":"LJA Spijkers","year":"2011","unstructured":"Spijkers LJA, van den Akker RFP, Janssen BJA, Debets JJ, De Mey JGR, Stroes ESG et al (2011) Hypertension is associated with marked alterations in sphingolipid biology: a potential role for ceramide. PLoS ONE 6(7):e21817","journal-title":"PLoS ONE"},{"issue":"1","key":"79_CR69","doi-asserted-by":"publisher","first-page":"96","DOI":"10.2174\/157489312799304431","volume":"7","author":"M Sugimoto","year":"2012","unstructured":"Sugimoto M, Kawakami M, Robert M, Soga T, Tomita M (2012) Bioinformatics tools for mass spectroscopy-based metabolomic data processing and analysis. Curr Bioinformatics 7(1):96\u2013108","journal-title":"Curr Bioinformatics"},{"issue":"3","key":"79_CR70","doi-asserted-by":"publisher","first-page":"e16","DOI":"10.1161\/01.CIR.0000075957.16003.07","volume":"108","author":"NK Sweitzer","year":"2003","unstructured":"Sweitzer NK (2003) What is an angiotensin converting enzyme inhibitor? Circulation 108(3):e16\u2013e18","journal-title":"Circulation"},{"issue":"5","key":"79_CR71","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1002\/mas.20306","volume":"30","author":"G Theodoridis","year":"2011","unstructured":"Theodoridis G, Gika HG, Wilson ID (2011) Mass spectrometry-based holistic analytical approaches for metabolite profiling in systems biology studies. Mass Spectrom Rev 30(5):884\u2013906","journal-title":"Mass Spectrom Rev"},{"key":"79_CR90","doi-asserted-by":"publisher","unstructured":"Thongboonkerd V (2005) Genomics, proteomics and integrative \u2018omics\u2019 in hypertension research. Curr Opin Nephrol Hypertens 14(2):133\u2013139","DOI":"10.1097\/00041552-200503000-00008"},{"issue":"2","key":"79_CR72","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/sj.bjp.0704862","volume":"137","author":"B Tom","year":"2002","unstructured":"Tom B, Dendorfer A, Rd V, Saxena PR, Jan Danser AH (2002) Bradykinin potentiation by ACE inhibitors: a matter of metabolism. Br J Pharmacol 137(2):276\u2013284","journal-title":"Br J Pharmacol"},{"issue":"2","key":"79_CR73","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jash.2014.11.007","volume":"9","author":"CA Deventer van","year":"2013","unstructured":"van Deventer CA, Lindeque JZ, van Rensburg PJJ, Malan L, van der Westhuizen FH, Louw R (2013) Use of metabolomics to elucidate the metabolic perturbation associated with hypertension in a black South African male cohort: the SABPA study. J Am Soc Hypertens 9(2):104\u2013114","journal-title":"J Am Soc Hypertens"},{"issue":"4","key":"79_CR74","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1291\/hypres.31.623","volume":"31","author":"S Wang","year":"2008","unstructured":"Wang S, Ma A, Song S, Quan Q, Zhao X, Zheng X (2008) Fasting serum free fatty acid composition, waist\/hip ratio and insulin activity in essential hypertensive patients. Hypertens Res 31(4):623\u2013632","journal-title":"Hypertens Res"},{"key":"79_CR75","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.aca.2014.11.009","volume":"854","author":"L Wang","year":"2015","unstructured":"Wang L, Hou E, Wang L, Wang Y, Yang L, Zheng X et al (2015) Reconstruction and analysis of correlation networks based on GC\u2013MS metabolomics data for young hypertensive men. Anal Chim Acta 854:95\u2013105","journal-title":"Anal Chim Acta"},{"issue":"2","key":"79_CR76","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1021\/pr060505+","volume":"6","author":"EJ Want","year":"2007","unstructured":"Want EJ, Nordstr\u00f6m A, Morita H, Siuzdak G (2007) From exogenous to endogenous: the inevitable imprint of mass spectrometry in metabolomics. J Proteome Res 6(2):459\u2013468","journal-title":"J Proteome Res"},{"issue":"13","key":"79_CR77","doi-asserted-by":"publisher","first-page":"5527","DOI":"10.1021\/ac100331b","volume":"82","author":"R Wei","year":"2010","unstructured":"Wei R, Li G, Seymour AB (2010) High-throughput and multiplexed LC\/MS\/MRM method for targeted metabolomics. Anal Chem 82(13):5527\u20135533","journal-title":"Anal Chem"},{"issue":"3","key":"79_CR78","doi-asserted-by":"publisher","first-page":"e57639","DOI":"10.1371\/journal.pone.0057639","volume":"8","author":"WR Wikoff","year":"2013","unstructured":"Wikoff WR, Frye RF, Zhu H, Gong Y, Boyle S, Churchill E et al (2013) Pharmacometabolomics reveals racial differences in response to atenolol treatment. PLoS ONE 8(3):e57639","journal-title":"PLoS ONE"},{"issue":"2","key":"79_CR79","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/S0022-3565(25)21471-9","volume":"230","author":"WA Wolf","year":"1984","unstructured":"Wolf WA, Kuhn DM (1984) Effects of L-tryptophan on blood pressure in normotensive and hypertensive rats. J Pharmacol Exp Ther 230(2):324\u2013329","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"79_CR80","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/nrm2335","volume":"9","author":"MP Wymann","year":"2008","unstructured":"Wymann MP, Schneiter R (2008) Lipid signalling in disease. Nat Rev Mol Cell Biol 9(2):162\u2013176","journal-title":"Nat Rev Mol Cell Biol"},{"key":"79_CR81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.trac.2011.08.009","volume":"32","author":"JF Xiao","year":"2012","unstructured":"Xiao JF, Zhou B, Ressom HW (2012) Metabolite identification and quantitation in LC-MS\/MS-based metabolomics. Trends Anal Chem 32:1\u201314","journal-title":"Trends Anal Chem"},{"key":"79_CR82","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.chroma.2014.11.050","volume":"1374","author":"P Yin","year":"2014","unstructured":"Yin P, Xu G (2014) Current state-of-the-art of nontargeted metabolomics based on liquid chromatography-mass spectrometry with special emphasis in clinical applications. J Chromatogr A 1374:1\u201313","journal-title":"J Chromatogr A"},{"issue":"17","key":"79_CR83","doi-asserted-by":"publisher","first-page":"4879","DOI":"10.1007\/s00216-015-8565-x","volume":"407","author":"P Yin","year":"2015","unstructured":"Yin P, Lehmann R, Xu G (2015) Effects of pre-analytical processes on blood samples used in metabolomics studies. Anal Bioanal Chem 407(17):4879\u20134892","journal-title":"Anal Bioanal Chem"},{"issue":"4","key":"79_CR84","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1111\/j.1523-1755.2004.00521.x","volume":"65","author":"K Yonemura","year":"2004","unstructured":"Yonemura K, Takahira R, Yonekawa O, Wada N, Hishida A (2004) The diagnostic value of serum concentrations of 2-(alpha-mannopyranosyl)-L-tryptophan for normal renal function. Kidney Int 65(4):1395\u20131399","journal-title":"Kidney Int"},{"key":"79_CR85","doi-asserted-by":"publisher","unstructured":"Zheng Y, Yu B, Alexander D, Manolio TA, Aguilar D, Coresh J et al (2013a) Associations between metabolomic compounds and incident heart failure among African Americans: the ARIC Study. Am J Epidemiol 178:534\u2013542","DOI":"10.1093\/aje\/kwt004"},{"issue":"2","key":"79_CR86","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1161\/HYPERTENSIONAHA.113.01166","volume":"62","author":"Y Zheng","year":"2013","unstructured":"Zheng Y, Yu B, Alexander D, Mosley TH, Heiss G, Nettleton JA et al (2013b) Metabolomics and incident hypertension among blacks the atherosclerosis risk in communities study. Hypertension 62(2):398\u2013403","journal-title":"Hypertension"},{"issue":"23","key":"79_CR87","first-page":"3673","volume":"18","author":"L Zhong","year":"2014","unstructured":"Zhong L, Zhang JP, Nuermaimaiti AG, Yunusi KX (2014) Study on plasmatic metabolomics of Uygur patients with essential hypertension based on nuclear magnetic resonance technique. Eur Rev Med Pharmacol Sci 18(23):3673\u20133680","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"3","key":"79_CR88","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S0895-7061(98)00178-2","volume":"12","author":"J Zicha","year":"1999","unstructured":"Zicha J, Kune\u0161 J, Devynck MA (1999) Abnormalities of membrane function and lipid metabolism in hypertension: a review. Am J Hypertens 12(3):315\u2013331","journal-title":"Am J Hypertens"}],"container-title":["Advances in Experimental Medicine and Biology","Hypertension: from basic research to clinical practice"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/5584_2016_79","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T03:33:20Z","timestamp":1749612800000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/5584_2016_79"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"ISBN":["9783319442501","9783319442518"],"references-count":90,"URL":"https:\/\/doi.org\/10.1007\/5584_2016_79","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}